10x Genomics, Inc. (TXG) Earnings Per Share (EPS)
10x Genomics, Inc. (TXG) diluted earnings per share by fiscal period. Track EPS in Excel with MarketXLS.
EPS (Earnings Per Share) Data
| Period | Diluted EPS (USD) |
|---|---|
| 2019-12-31 | -$0.80 |
| 2020-12-31 | -$5.37 |
| 2021-12-31 | -$0.53 |
| 2022-12-31 | -$1.46 |
| 2023-12-31 | -$2.18 |
| 2024-12-31 | -$1.52 |
| 2025-12-31 | -$0.35 |
How TXG compares with sector peers
| Symbol | Company | Diluted EPS (latest fiscal year) |
|---|---|---|
| DYAI | Dyadic International Inc. | -$0.23 |
| MNOV | MediciNova Inc. | -$0.24 |
| TRVI | Trevi Therapeutics Inc. | -$0.32 |
| ACRS | Aclaris Therapeutics Inc. | -$0.53 |
| CRVS | Corvus Pharmaceuticals Inc. | -$0.53 |
These are five companies in the same sector as TXG with a comparable annual diluted earnings per share. Each figure above is that company's most recent completed fiscal year, read from the same annual statements as the table on its own page, so the period end dates can differ between rows.
Get 10x Genomics, Inc. Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =EarningsPerShare("TXG")
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | TXG | $56.09 | +0.00% | 2.87M |
| 3 | ||||
| 4 | ||||
| 5 |